Our research focuses on improving the functionality of CRISPR-Cas9 and related platforms to make them more suitable for industrial applications, thereby placing us at the forefront of the genome editing field.


Toolgen is positioning itself as a leader in the field of CRISPR-Cas9 technology by actively engaging in research and development, patent acquisition, safety evaluation measures, and advancements to improve the functionality of CRISPR-Cas9. The technology's versatility allows it to be applied across a wide range of fields, similar to the way existing drugs can generate multiple candidate substances. Additionally, we are exploring opportunities to expand our business by utilizing this platform technology.

Optimizing CRISPR-Cas9

CRISPR safety evaluation technology

New business expansion using CRISPR